Inappropriate vitamin D supplementation among multimorbid older patients: a multicountry analysis.
Options
BORIS DOI
Publisher DOI
PubMed ID
40684074
Description
Background
The prevalence of vitamin D supplementation and the percentage of participants with a lack of appropriate vitamin D supplementation ("potential underuse") or potentially inappropriate vitamin D supplementation ("potential overuse") and risk factors for these are currently unclear.Methods
Cross-sectional analysis from the OPERAM study, a multicenter cluster randomized controlled trial in four European countries (Belgium, Ireland, The Netherlands, Switzerland) including multimorbid (≥ 3 chronic conditions) older patients, with polypharmacy (≥ 5 chronic medications). For the definition of potential underuse and overuse we used high-risk conditions, which were defined according to the START criteria (version 2) for potential prescribing omissions in older people i.e., E2) long-term systemic corticosteroid therapy, known osteoporosis or osteopenia, E3) previous fragility fractures, and E5) housebound/in nursing homes or experiencing falls. We used mixed effect logistic regression to identify factors associated with underuse and overuse.Results
2008 patients (79.4y, SD 6.3, 45% female) were included. 825/2008 (41.1%) were supplemented with vitamin D. We identified 681 participants with potential underuse (33.9% of all participants, 69.7% of non-vitamin D users) and 204 with potential overuse (10.2% of all participants, 24.7% of vitamin D users). In the multivariable logistic regression analysis increasing age and being male were associated with underuse, while the number of baseline medications and previous hospitalizations were associated with both underuse and overuse. Specifically, underuse decreased with an increasing number of medications (OR: 0.93, 95% CI: 0.90-0.95), while overuse increased (OR: 1.08, 95% CI: 1.04-1.12). Previous hospitalizations were linked to underuse (OR: 1.08, 95% CI: 1.00-1.17) and inversely associated with overuse (OR: 0.88, 95% CI: 0.77-0.99).Conclusions
One-third of multimorbid older adults experienced potential underuse, while up to 10% potential overuse of vitamin D supplementation. Polypharmacy, previous hospitalizations, increasing age and being male are factors associated with inappropriate use of vitamin D. A better targeted vitamin D supplementation is warranted.Trial Registration
NCT02986425, Registration date 2016-10-21.
The prevalence of vitamin D supplementation and the percentage of participants with a lack of appropriate vitamin D supplementation ("potential underuse") or potentially inappropriate vitamin D supplementation ("potential overuse") and risk factors for these are currently unclear.Methods
Cross-sectional analysis from the OPERAM study, a multicenter cluster randomized controlled trial in four European countries (Belgium, Ireland, The Netherlands, Switzerland) including multimorbid (≥ 3 chronic conditions) older patients, with polypharmacy (≥ 5 chronic medications). For the definition of potential underuse and overuse we used high-risk conditions, which were defined according to the START criteria (version 2) for potential prescribing omissions in older people i.e., E2) long-term systemic corticosteroid therapy, known osteoporosis or osteopenia, E3) previous fragility fractures, and E5) housebound/in nursing homes or experiencing falls. We used mixed effect logistic regression to identify factors associated with underuse and overuse.Results
2008 patients (79.4y, SD 6.3, 45% female) were included. 825/2008 (41.1%) were supplemented with vitamin D. We identified 681 participants with potential underuse (33.9% of all participants, 69.7% of non-vitamin D users) and 204 with potential overuse (10.2% of all participants, 24.7% of vitamin D users). In the multivariable logistic regression analysis increasing age and being male were associated with underuse, while the number of baseline medications and previous hospitalizations were associated with both underuse and overuse. Specifically, underuse decreased with an increasing number of medications (OR: 0.93, 95% CI: 0.90-0.95), while overuse increased (OR: 1.08, 95% CI: 1.04-1.12). Previous hospitalizations were linked to underuse (OR: 1.08, 95% CI: 1.00-1.17) and inversely associated with overuse (OR: 0.88, 95% CI: 0.77-0.99).Conclusions
One-third of multimorbid older adults experienced potential underuse, while up to 10% potential overuse of vitamin D supplementation. Polypharmacy, previous hospitalizations, increasing age and being male are factors associated with inappropriate use of vitamin D. A better targeted vitamin D supplementation is warranted.Trial Registration
NCT02986425, Registration date 2016-10-21.
Date of Publication
2025-07-19
Publication Type
Article
Subject(s)
600 - Technology::610 - Medicine & health
Keyword(s)
Inappropriate prescribing
•
Older adults
•
Overuse
•
Vitamin D
Language(s)
en
Contributor(s)
Dalleur, Olivia | |
Knol, Wilma | |
Emmelot-Vonk, Marielle | |
O'Mahony, Denis | |
Boland, Benoit | |
Spinewine, Anne |
Additional Credits
Institute of General Practice and Primary Care (BIHAM)
Institut für Spitalpharmazie
Clinic of General Internal Medicine
Clinic of General Internal Medicine
Berner Institut für Hausarztmedizin (BIHAM) - SC-Team Moutzouri
Berner Institut für Hausarztmedizin (BIHAM) - SC-Team Feller
Berner Institut für Hausarztmedizin (BIHAM) - Ageing
Series
BMC Geriatrics
Publisher
BioMed Central
ISSN
1471-2318
Related URL(s)
https://clinicaltrials.gov/study/NCT02986425
Access(Rights)
open.access